secwatch.observer — SEC 8-K summary
======================================

Issuer:     Bausch Health Companies Inc. (BHC)
CIK:        0000885590
Form:       8-K
Filed at:   2023-07-07T23:59:59+00:00
Accession:  0001193125-23-183310
Event type: debt
Sentiment:  neutral
Materiality: 0.55
Item codes: 1.01, 2.03, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Bausch Health enters $600M non-recourse receivables financing with KKR
----------------------------------------------------------------------

- $600M revolving credit facility collateralized by accounts receivables, matures January 28, 2028.
- Interest at 1-month Term SOFR plus 6.65%; proceeds for general corporate purposes.
- Facility is non-recourse to Bausch Health, structured through subsidiary Bausch Receivables Funding LP.
- KKR acted as left lead arranger and structuring advisor; Houlihan Lokey financial advisor.
- Facility provides approximately five-year term liquidity; Finacity Corporation as program administrator.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/885590/000119312523183310/0001193125-23-183310-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/885590/000119312523183310/d478804d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-183310

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer